METTL3 knockdown or pharmacologic inhibition of the METTL3/14 complex with STM2457 decreased the proliferation of a panel of adrenergic neuroblastoma cells, including cells that harbored amplification of the MYCN oncogene. Here, METTL3 is linked to neuroblastoma.